EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Edwards Lifesciences (EW) Misses Q4 EPS by 4c, Offers Guidance
January 26, 2022 4:17 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.51, $0.04 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.36 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2022 EPS of $0.54-$0.62, versus the consensus of $0.60.... More
